Hajj Aline, Hallit Souheil, Ramia Elsy, Salameh Pascale
a Laboratoire de Pharmacologie, Pharmacie clinique et Contrôle de Qualité des médicaments, Pôle Technologie- Santé (PTS), Faculty of Pharmacy , Saint-Joseph University , Beirut , Lebanon.
b Saint-Joseph University , School of Pharmacy , Beirut , Lebanon.
Curr Med Res Opin. 2018 Jan;34(1):149-156. doi: 10.1080/03007995.2017.1361916. Epub 2017 Aug 30.
The effectiveness of a national post-marketing surveillance program depends directly on the active participation of all health professionals. There is no current comprehensive and active pharmacovigilance program available in Lebanon.
To assess the knowledge, attitudes, and practices (KAP) among community pharmacists in Lebanon with respect to potential pharmacovigilance and adverse-drug-reaction reporting in Lebanon.
A cross-sectional descriptive study, using a self-administered KAP questionnaire and conducted between March and July 2016, included 1857 pharmacists practicing in community settings. Statistical analysis included χ test for dichotomous or multinomial qualitative variables, and Wilcoxon test for quantitative variables with non-homogeneous variances or non-normal distribution.
The majority of responders had good knowledge concerning the concept and purpose of pharmacovigilance as well as adverse drug reactions (how to report these/the importance of reporting adverse events/the definition of an adverse event and pharmacovigilance). Concerning community pharmacists' attitudes and practice towards pharmacovigilance, the majority described having a positive attitude towards their role in adverse drug reaction reporting and this activity was even seen as one of their core duties. The questionnaire revealed a lack of practice and training regarding pharmacovigilance. Nonetheless, the pharmacists agreed on the Order of Pharmacists in Lebanon and the Ministry of Health's role in promoting this practice and helping them be more involved in reporting adverse drug reactions (ADRs). The pharmacists thought that they are well positioned regarding patient-safety practice in their pharmacies and the results were not statistically different between pharmacy employers and employees.
Lebanese pharmacists have the required knowledge and positive attitude to start reporting ADRs, were aware of ADRs occurring with various medicines post-marketing, yet were currently not able to disseminate this information widely or to record it centrally, emphasizing the importance of establishing a national ADR reporting system.
国家上市后监测计划的有效性直接取决于所有卫生专业人员的积极参与。黎巴嫩目前没有全面且积极的药物警戒计划。
评估黎巴嫩社区药剂师在潜在药物警戒和黎巴嫩药品不良反应报告方面的知识、态度和实践(KAP)。
一项横断面描述性研究,于2016年3月至7月间使用自行填写的KAP问卷,纳入了1857名在社区药房工作的药剂师。统计分析包括对二分或多项定性变量的χ检验,以及对方差不齐或分布非正态的定量变量的Wilcoxon检验。
大多数受访者对药物警戒的概念和目的以及药品不良反应(如何报告这些反应/报告不良事件的重要性/不良事件和药物警戒的定义)有较好的了解。关于社区药剂师对药物警戒的态度和实践,大多数人表示对他们在药品不良反应报告中的作用持积极态度,并且这项活动甚至被视为他们的核心职责之一。问卷显示在药物警戒方面缺乏实践和培训。尽管如此,药剂师认可黎巴嫩药剂师协会以及卫生部在促进这种实践并帮助他们更多地参与报告药品不良反应方面所起的作用。药剂师认为他们在药房的患者安全实践方面处于有利地位,药房雇主和雇员之间的结果在统计学上没有差异。
黎巴嫩药剂师具备开始报告药品不良反应所需的知识和积极态度,意识到各种药品上市后会出现不良反应,但目前无法广泛传播这些信息或集中记录,这凸显了建立国家药品不良反应报告系统的重要性。